BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 7539555)

  • 1. Association of down-regulation of cytokine activity with rat hind limb allograft survival.
    Fealy MJ; Most D; Huie P; Wolf M; Sibley RK; Morris RE; Press BH
    Transplantation; 1995 May; 59(10):1475-80. PubMed ID: 7539555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival.
    Fealy MJ; Umansky WS; Bickel KD; Nino JJ; Morris RE; Press BH
    Ann Surg; 1994 Jan; 219(1):88-93. PubMed ID: 7507657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of allograft rejection in an experimental model of small intestinal transplantation.
    Hayashi M; Martinez OM; Krams SM; Burns W; Esquivel CO
    J Gastrointest Surg; 1998; 2(4):325-32. PubMed ID: 9841989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
    Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice.
    Xia D; Sanders A; Shah M; Bickerstaff A; Orosz C
    Transplantation; 2001 Sep; 72(5):907-14. PubMed ID: 11571458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intragraft cytokine mRNA expression in rejecting and non-rejecting vascularized xenografts.
    Lorant T; Krook H; Wilton J; Olausson M; Tufveson G; Korsgren O; Johnsson C
    Xenotransplantation; 2003 Jul; 10(4):311-24. PubMed ID: 12795680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous administration of a neutralizing IL-1β antibody prolongs limb allograft survival.
    Hautz T; Grahammer J; Moser D; Eberhart N; Zelger B; Zelger B; Blumer MJ; Drasche A; Wolfram D; Troppmair J; Öfner D; Schneeberger S
    Am J Transplant; 2018 Aug; 18(8):2029-2042. PubMed ID: 29633557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
    Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV
    Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
    Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
    Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.
    Shirwan H; Barwari L; Khan NS
    Transplantation; 1998 Dec; 66(12):1802-9. PubMed ID: 9884279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection.
    Loong CC; Hsieh HG; Lui WY; Chen A; Lin CY
    J Pathol; 2002 Jul; 197(3):322-32. PubMed ID: 12115878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytes of composite tissue allografts express elevated levels of TGF beta mRNA and protein during chronic rejection.
    Walgenbach KJ; Llull R; Murase N; Starzl TE; Hirner A
    Transplant Proc; 1997; 29(1-2):1542. PubMed ID: 9123418
    [No Abstract]   [Full Text] [Related]  

  • 16. The correlation of intragraft cytokine expression with rejection in rat small intestine transplantation.
    McDiarmid SV; Farmer DG; Kuniyoshi JS; Robert M; Khadavi A; Shaked A; Busuttil RW
    Transplantation; 1994 Sep; 58(6):690-7. PubMed ID: 7940688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine and chemokine expression kinetics after corneal transplantation.
    King WJ; Comer RM; Hudde T; Larkin DF; George AJ
    Transplantation; 2000 Oct; 70(8):1225-33. PubMed ID: 11063345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study.
    Ulusal BG; Ulusal AE; Hung LM; Wei FC
    J Surg Res; 2006 Apr; 131(2):261-6. PubMed ID: 16457843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation.
    Levay-Young B; Gruessner SE; Shearer JD; Cheol Kim S; Nahkleh RE; Gruessner RW
    J Surg Res; 2003 Sep; 114(1):78-89. PubMed ID: 13678702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.